Fine Foods & Pharmaceuticals N.T.M Balance Sheet Health
Financial Health criteria checks 4/6
Fine Foods & Pharmaceuticals N.T.M has a total shareholder equity of €128.4M and total debt of €61.5M, which brings its debt-to-equity ratio to 47.9%. Its total assets and total liabilities are €239.8M and €111.4M respectively. Fine Foods & Pharmaceuticals N.T.M's EBIT is €9.8M making its interest coverage ratio 2.4. It has cash and short-term investments of €15.2M.
Key information
47.9%
Debt to equity ratio
€61.53m
Debt
Interest coverage ratio | 2.4x |
Cash | €15.21m |
Equity | €128.40m |
Total liabilities | €111.41m |
Total assets | €239.81m |
Recent financial health updates
Recent updates
Solid Earnings Reflect Fine Foods & Pharmaceuticals N.T.M's (BIT:FF) Strength As A Business
Sep 20Is There An Opportunity With Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s (BIT:FF) 40% Undervaluation?
Apr 28Estimating The Fair Value Of Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF)
Mar 20Something To Consider Before Buying Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF) For The 1.1% Dividend
Feb 22A Look At Fine Foods & Pharmaceuticals N.T.M's (BIT:FF) Share Price Returns
Feb 01What You Need To Know About Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s (BIT:FF) Investor Composition
Jan 14We Wouldn't Rely On Fine Foods & Pharmaceuticals N.T.M's (BIT:FF) Statutory Earnings As A Guide
Dec 28Is Fine Foods & Pharmaceuticals N.T.M (BIT:FF) Using Too Much Debt?
Dec 08Financial Position Analysis
Short Term Liabilities: FF's short term assets (€106.4M) exceed its short term liabilities (€67.6M).
Long Term Liabilities: FF's short term assets (€106.4M) exceed its long term liabilities (€43.8M).
Debt to Equity History and Analysis
Debt Level: FF's net debt to equity ratio (36.1%) is considered satisfactory.
Reducing Debt: FF's debt to equity ratio has increased from 21.4% to 47.9% over the past 5 years.
Debt Coverage: FF's debt is well covered by operating cash flow (64.9%).
Interest Coverage: FF's interest payments on its debt are not well covered by EBIT (2.4x coverage).